Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension

NCT06212648 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

253

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Essential Hypertension

Interventions

DRUG: SPC1001 High
DRUG: SPC1001 Mid1
DRUG: SPC1001 Mid2
DRUG: SPC1001 Low
DRUG: SPC3001
DRUG: SPC4001
DRUG: SPC4002
DRUG: Placebo

Sponsor

Shin Poong Pharmaceutical Co. Ltd.